文献速递炎症性肠病

二氧化钛纳米颗粒消除克罗恩病相关PTPN22基因变异位的保护效应

TiO2 nanoparticles abrogate the protective effect of the Crohn's disease-associated variation within the PTPN22 gene locus.
PubMed 文献 · Gut · 2022-10-03

该研究在小鼠急性DSS结肠炎模型中探讨PTPN22-R619W变异与二氧化钛纳米颗粒的交互作用。结果显示,给予二氧化钛纳米颗粒消除了该变异的保护效应,使PTPN22-R619W小鼠易感DSS结肠炎,并伴随细胞毒性CD8+ T细胞减少被逆转、Ifng表达增加及促炎巨噬细胞增多。作者认为携带该变异者摄入二氧化钛纳米颗粒可能对胃肠道健康产生不良影响。

要点

  • PTPN22-R619W小鼠在急性DSS结肠炎模型中受保护,但给予二氧化钛纳米颗粒后保护效应被消除。
  • 二氧化钛逆转了PTPN22-R619W小鼠固有层细胞毒性CD8+ T细胞减少,并增加Ifng表达。
  • 作者认为携带PTPN22变异者摄入二氧化钛纳米颗粒可能对胃肠道健康有不良影响。

核心结论

  • 作者认为,摄入二氧化钛纳米颗粒可能对携带PTPN22变异个体的胃肠道健康产生不良影响。
  • 环境因素可与遗传风险变异交互作用,并将保护机制逆转为促病效应。

研究设计与样本

  • 在野生型小鼠与PTPN22-R619W变异小鼠中诱导急性DSS结肠炎,并在结肠炎诱导期间给予二氧化钛纳米颗粒处理。
  • 采用bulk与单细胞RNA测序探究疾病触发机制。

主要发现

  • 在小鼠中,给予二氧化钛纳米颗粒消除了该变异的保护效应,使PTPN22-R619W小鼠对DSS结肠炎易感。
  • 疾病早期,PTPN22-R619W小鼠固有层细胞毒性CD8+ T细胞减少,二氧化钛处理逆转了该效应。
  • T细胞群体正常化与Ifng表达增加相关,并在疾病后期促进促炎巨噬细胞增多,触发严重肠道炎症。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Inflammatory bowel disease (IBD) is a multifactorial condition driven by genetic and environmental risk factors. A genetic variation in the protein tyrosine phosphatase non-receptor type 22 (PTPN22) gene has been associated with autoimmune disorders while protecting from the IBD subtype Crohn's disease. Mice expressing the murine orthologous PTPN22-R619W variant are protected from intestinal inflammation in the model of acute dextran sodium sulfate (DSS)-induced colitis. We previously identified food-grade titanium dioxide (TiO2, E171) as a neglected IBD risk factor. Here, we investigate the interplay of the PTPN22 variant and TiO2-mediated effects during IBD pathogenesis. DESIGN: Acute DSS colitis was induced in wild-type and PTPN22 variant mice (PTPN22-R619W) and animals were treated with TiO2 nanoparticles during colitis induction. Disease-triggering mechanisms were investigated using bulk and single-cell RNA sequencing. RESULTS: In mice, administration of TiO2 nanoparticles abrogated the protective effect of the variant, rendering PTPN22-R619W mice susceptible to DSS colitis. In early disease, cytotoxic CD8+ T-cells were found to be reduced in the lamina propria of PTPN22-R619W mice, an effect reversed by TiO2 administration. Normalisation of T-cell populations correlated with increased Ifng expression and, at a later stage of disease, the promoted prevalence of proinflammatory macrophages that triggered severe intestinal inflammation. CONCLUSION: Our findings indicate that the consumption of TiO2 nanoparticles might have adverse effects on the gastrointestinal health of individuals carrying the PTPN22 variant. This demonstrates that environmental factors interact with genetic risk variants and can reverse a protective mechanism into a disease-promoting effect.

来源:Gut,查看原文。版权归原作者所有。

引用

  1. Schwarzfischer M, Niechcial A, Handler K, et al. TiO2 nanoparticles abrogate the protective effect of the Crohn's disease-associated variation within the PTPN22 gene locus. Gut. 2022. PMID: 36191962. doi:10.1136/gutjnl-2021-325911

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。